SML0197

4E1RCat

≥97% (HPLC)

• 別名: 4-[(3E)-3-[[5-(4-nitrophenyl)furan-2-yl]methylidene]-2-oxo-5-phenylpyrrol-1-yl]benzoic acid
• 実験式（ヒル表記法）: C₂₈H₁₈N₂O₆
• CAS番号: 328998-25-0
• 分子量: 478.45
• MDL番号: MFCD01931282
• UNSPSCコード: 12352200
• PubChem Substance ID: 329825222
• NACRES: NA.77

特性

• 品質水準: 100
• アッセイ: ≥97% (HPLC)
• フォーム: powder
• 色: faint brown to dark brown-red
• 溶解性: DMSO: ≥5 mg/mL
• オーガナイザー: Merck & Co., Inc., Kenilworth, NJ, U.S.
• 保管温度: 2-8°C
• SMILES記法: OC(=O)c1ccc(cc1)N2C(=O)\C(=C\c3ccc(o3)-c4ccc(cc4)[N+]([O-])=O)C=C2c5ccccc5
• InChI: 1S/C28H18N2O6/c31-27-21(16-24-14-15-26(36-24)19-6-12-23(13-7-19)30(34)35)17-25(18-4-2-1-3-5-18)29(27)22-10-8-20(9-11-22)28(32)33/h1-17H,(H,32,33)/b21-16+
• InChI Key: BBQRBOIMSKMFFO-LTGZKZEYSA-N

詳細

アプリケーション

4E1RCat was used to inhibit new protein synthesis in transformed primary chicken embryo fibroblasts.

生物化学的／生理学的作用

4E1RCat ilnhibits the eIF4F translation initiation complex by binding to IF4E b and inhibiting the interaction between IF4E:eIF4G (IC₅₀ = 3.2 μM). In in vitro translation experiments using MDA-MB-231 cells, 4E1RCat dose dependently inhibited cap-dependent translation, led to a decrease in polysome and 80S ribosomal subunits and reduced levels of the eIF4F-dependant proteins Mcl-1 and c-Myc.

4E1RCat is an inhibitor of translation initiation complex eIF4F

特徴および利点

This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the MAPKAPs page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable